Name: MSRB3-set siRNA/shRNA/RNAi Lentivector (Human) | 307590910395
Brand: 171
SKU: 171-307590910395
Price: 1500.00 EUR
Availability: InStock

MSRB3-set siRNA/shRNA/RNAi Lentivector (Human) | 307590910395

(No reviews yet) Write a Review

SKU:

171-307590910395

Availability:

IN STOCK

Description
Additional Information

Description

MSRB3-set siRNA/shRNA/RNAi Lentivector (Human) | 307590910395 | Gentaur UK, US & Europe Distribution

Product Name	MSRB3-set siRNA/shRNA/RNAi Lentivector (Human)
Accession Number	NM_001031679
Cat.No	307590910395
Gene Name	MSRB3
Full Gene Name	methionine sulfoxide reductase B3
Aliases	FLJ36866, DKFZp686C1178
List of species	Human
Units	4 x 500 ng
Vector	piLenti-siRNA-GFP
Applications	Direct non-viral plasmid transfection for immediate expression Package into lentiviral particles for high efficiency transduction and stably integrated expression
System	Lentiviral Vector
List of Markers	Puromycin
Target Sequence	Target a-63 TGGGCTTCCCTCAGGGTCGTGTAGGGATA Target b-236 GTGTTGTTTGTGGAACTCCAT Target c-302 CATTCCACGATGTGATCAATT Target d-383 GCTCTCAGTGTGGTGCTCACCTTGGGCAC
Appearance	Liquid
Vector Size	8603bp
Format	Plasmid
Storage	-20°C or below
Shelf Life	1 year (when at -20°C or below in a non-frost free freezer)
QC	Restriction Enzyme Digest and Sequencing
Shipping Conditions	Shipped at ambient temperature
Lead Time	Inquire
Disclaimer	1. Disclaimer for accession number: The provided accession number refers to the transcript (mRNA) sequence the siRNA product targets. Please verify that this is the desired transcript sequence by cross-referencing. This is important because a single gene can have multiple different transcripts owing to naturally occurring variations. All sales are final. 2. Disclaimer for intended use: All of abm's vectors and viral particles are for research use ONLY and NOT for therapeutic/diagnostic applications. abm is not liable for any repercussions arising from the use of its vector(s) in therapeutic/diagnostic application(s). 3. Disclaimer for extra nucleotides: Cloning may lead to the insertion of extra nucleotides at the 5' or 3' end of the target sequence which, in most cases, is innocuous to the stability/functionality of the construct.